Soon after Bharat Biotech’s Covaxin became the first indigenous vaccine candidate to get the nod for clinical trials, Ahmedabad’s Zydus Cadila Healthcare has also received the approval from the Drugs Controller General of India (DCGI) to conduct human trials for its vaccine, PTI reported quoting government sources.
An official source told the news agency,